Difference between revisions of "The Jericho Foundation"
From TheHolo.Net Forums Wiki
(→Facilities) |
m |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{Quote|Because they're our future, too. The Jericho Center for Genetic Medicine.|Billboard advertisement in New York}} | {{Quote|Because they're our future, too. The Jericho Center for Genetic Medicine.|Billboard advertisement in New York}} | ||
| − | '''The Jericho Foundation''' is an international biomedical research organization dedicated to studying the mutant phenomenon. Jericho operates a number of laboratories and clinics around the world, from consulting offices to entire hospital campuses. Officially, their mission is to create pharmaceutical and technological solutions for a world populated by mutants. However, their methods and their treatment of mutant patients | + | '''The Jericho Foundation''' is an international biomedical research organization dedicated to studying the mutant phenomenon. Jericho operates a number of laboratories and clinics around the world, from consulting offices to entire hospital campuses. Officially, their mission is to create pharmaceutical and technological solutions for a world populated by mutants. However, their methods and their treatment of mutant patients indicate that they may have more sinister goals. |
The Jericho Foundation has been recognized as the leading developer of mutant-related technology in the United States and has received numerous government grants in exchange for products that now enjoy widespread use by hospitals and law enforcement agencies. | The Jericho Foundation has been recognized as the leading developer of mutant-related technology in the United States and has received numerous government grants in exchange for products that now enjoy widespread use by hospitals and law enforcement agencies. | ||
| Line 10: | Line 10: | ||
=== Facilities === | === Facilities === | ||
| − | * '''The Jericho Center for Genetic Medicine''' is the largest facility operated by the Jericho Foundation in the United States. Located in | + | |
| + | The Jericho Foundation operates numerous facilities around the world in order to study the largest possible cross-section of the mutant subspecies. These facilities vary in their size, purpose, and transparency to the public. | ||
| + | |||
| + | * '''The Jericho Center for Genetic Medicine''' is the largest facility operated by the Jericho Foundation in the United States. Located in a secluded valley near the border between New York and Connecticut, the Center, sometimes called "Jericho East," consists of nearly a dozen buildings surrounded by a high-security perimeter. The facilities include an extensive underground compound of laboratories, operating rooms, and holding cells for mutant patients deemed either too dangerous or too valuable to keep at the surface. These underground facilities are kept secret from the public. It was here that [[Jamie Morrigan]] was held before she was rescued by [[Dragon]] and [[Spectre]]. | ||
* '''The Jozua Clinic''' | * '''The Jozua Clinic''' | ||
| + | |||
| + | |||
| + | === Technology === | ||
| + | |||
| + | Among the Jericho Foundation's core goals is to develop biomedical technology to address the challenges of the mutant phenomenon. Some of this technology is made freely available to governments, hospitals, and law enforcement agencies, while other items are reserved for a privileged few. | ||
| + | |||
| + | * '''Suppression collars''' are wearable devices that can suppress the effects of the X-gene, effectively neutralizing a mutant's powers. Suppression collars may be equipped with remote control devices so they may be activated or deactivated at a distance. They may also be equipped with electrical feedback systems that deliver painful shocks to the wearer in order to discourage tampering. These devices are available for purchase by licensed hospitals and law enforcement agencies. | ||
| + | |||
| + | * '''Nectar (neocortisine)''' is a liquid drug that produces only mild hallucinogenic effects in humans but rather severe effects in mutants. Even small amounts of the drug can cause a mutant's powers to go out of control, often with catastrophic results. When the primary effects of the drug wear off, the affected mutant is rendered powerless for hours. Nectar is currently only available from laboratories in South America. Jericho uses a number of illicit means, including third-party drug runners like the Tres Onces street gang, to transport the drug to their facilities. Once refined, Nectar may be used in combinations with other drugs to exert finer control over a mutant's abilities. | ||
=== Personnel === | === Personnel === | ||
Latest revision as of 02:25, 22 March 2012
- "Because they're our future, too. The Jericho Center for Genetic Medicine."
- ―Billboard advertisement in New York
The Jericho Foundation is an international biomedical research organization dedicated to studying the mutant phenomenon. Jericho operates a number of laboratories and clinics around the world, from consulting offices to entire hospital campuses. Officially, their mission is to create pharmaceutical and technological solutions for a world populated by mutants. However, their methods and their treatment of mutant patients indicate that they may have more sinister goals.
The Jericho Foundation has been recognized as the leading developer of mutant-related technology in the United States and has received numerous government grants in exchange for products that now enjoy widespread use by hospitals and law enforcement agencies.
Contents |
History
Facilities
The Jericho Foundation operates numerous facilities around the world in order to study the largest possible cross-section of the mutant subspecies. These facilities vary in their size, purpose, and transparency to the public.
- The Jericho Center for Genetic Medicine is the largest facility operated by the Jericho Foundation in the United States. Located in a secluded valley near the border between New York and Connecticut, the Center, sometimes called "Jericho East," consists of nearly a dozen buildings surrounded by a high-security perimeter. The facilities include an extensive underground compound of laboratories, operating rooms, and holding cells for mutant patients deemed either too dangerous or too valuable to keep at the surface. These underground facilities are kept secret from the public. It was here that Jamie Morrigan was held before she was rescued by Dragon and Spectre.
- The Jozua Clinic
Technology
Among the Jericho Foundation's core goals is to develop biomedical technology to address the challenges of the mutant phenomenon. Some of this technology is made freely available to governments, hospitals, and law enforcement agencies, while other items are reserved for a privileged few.
- Suppression collars are wearable devices that can suppress the effects of the X-gene, effectively neutralizing a mutant's powers. Suppression collars may be equipped with remote control devices so they may be activated or deactivated at a distance. They may also be equipped with electrical feedback systems that deliver painful shocks to the wearer in order to discourage tampering. These devices are available for purchase by licensed hospitals and law enforcement agencies.
- Nectar (neocortisine) is a liquid drug that produces only mild hallucinogenic effects in humans but rather severe effects in mutants. Even small amounts of the drug can cause a mutant's powers to go out of control, often with catastrophic results. When the primary effects of the drug wear off, the affected mutant is rendered powerless for hours. Nectar is currently only available from laboratories in South America. Jericho uses a number of illicit means, including third-party drug runners like the Tres Onces street gang, to transport the drug to their facilities. Once refined, Nectar may be used in combinations with other drugs to exert finer control over a mutant's abilities.
Personnel
Appearances
Mutant operatives infiltrated the Jericho Center in Connecticut to abduct Jamie Morrigan, a young girl who was scheduled for a transfer to Vanguard's primary facility in Montana.
